全文获取类型
收费全文 | 2391743篇 |
免费 | 182530篇 |
国内免费 | 4596篇 |
专业分类
耳鼻咽喉 | 31753篇 |
儿科学 | 78845篇 |
妇产科学 | 68021篇 |
基础医学 | 348058篇 |
口腔科学 | 66119篇 |
临床医学 | 220311篇 |
内科学 | 468750篇 |
皮肤病学 | 53609篇 |
神经病学 | 194949篇 |
特种医学 | 89743篇 |
外国民族医学 | 702篇 |
外科学 | 347588篇 |
综合类 | 53632篇 |
现状与发展 | 4篇 |
一般理论 | 972篇 |
预防医学 | 193853篇 |
眼科学 | 54465篇 |
药学 | 171666篇 |
7篇 | |
中国医学 | 4906篇 |
肿瘤学 | 130916篇 |
出版年
2019年 | 19195篇 |
2018年 | 26495篇 |
2017年 | 20249篇 |
2016年 | 22590篇 |
2015年 | 25524篇 |
2014年 | 35946篇 |
2013年 | 54290篇 |
2012年 | 73589篇 |
2011年 | 78483篇 |
2010年 | 45950篇 |
2009年 | 44008篇 |
2008年 | 73192篇 |
2007年 | 77978篇 |
2006年 | 78004篇 |
2005年 | 75942篇 |
2004年 | 72915篇 |
2003年 | 69636篇 |
2002年 | 67435篇 |
2001年 | 111880篇 |
2000年 | 114228篇 |
1999年 | 95380篇 |
1998年 | 27152篇 |
1997年 | 24639篇 |
1996年 | 24965篇 |
1995年 | 23686篇 |
1994年 | 21770篇 |
1993年 | 20362篇 |
1992年 | 73839篇 |
1991年 | 71700篇 |
1990年 | 69065篇 |
1989年 | 66519篇 |
1988年 | 61326篇 |
1987年 | 59965篇 |
1986年 | 56561篇 |
1985年 | 53747篇 |
1984年 | 41008篇 |
1983年 | 35276篇 |
1982年 | 21190篇 |
1981年 | 19183篇 |
1979年 | 37631篇 |
1978年 | 27188篇 |
1977年 | 22653篇 |
1976年 | 21212篇 |
1975年 | 22320篇 |
1974年 | 27119篇 |
1973年 | 26455篇 |
1972年 | 24942篇 |
1971年 | 22981篇 |
1970年 | 21720篇 |
1969年 | 20359篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
51.
52.
Benyam Kinde Harrison W. Gabel Caitlin S. Gilbert Eric C. Griffith Michael E. Greenberg 《Proceedings of the National Academy of Sciences of the United States of America》2015,112(22):6800-6806
DNA methylation at CpG dinucleotides is an important epigenetic regulator common to virtually all mammalian cell types, but recent evidence indicates that during early postnatal development neuronal genomes also accumulate uniquely high levels of two alternative forms of methylation, non-CpG methylation and hydroxymethylation. Here we discuss the distinct landscape of DNA methylation in neurons, how it is established, and how it might affect the binding and function of protein readers of DNA methylation. We review studies of one critical reader of DNA methylation in the brain, the Rett syndrome protein methyl CpG-binding protein 2 (MeCP2), and discuss how differential binding affinity of MeCP2 for non-CpG and hydroxymethylation may affect the function of this methyl-binding protein in the nervous system. 相似文献
53.
Provocation of Atrial Fibrillation Triggers During Ablation: Does the Use of General Anesthesia Affect Inducibility? 下载免费PDF全文
54.
55.
C. Dessinioti C.C. Zouboulis V. Bettoli D. Rigopoulos 《Journal of the European Academy of Dermatology and Venereology》2020,34(10):2229-2240
Guidelines and consensus on the management of patients with acne aim to give evidence-based, expert-group recommendations. This review compares current guidelines and consensus articles to provide a compilation of recommendations on the treatment of acne with oral isotretinoin. Ten common, relevant, clinical questions are addressed, based on published recommendations, including the indications of isotretinoin, the proposed daily dose, the cumulative isotretinoin dose and the laboratory monitoring needed. Recommendations on special considerations are also addressed, including the timing of procedures and the question of an association of depression or inflammatory bowel disease with isotretinoin. A major limitation is the use of different classification systems for acne across guidelines. The recommended daily dose ranges from 0.3 to 0.5 mg/kg in the European guidelines to up to 1 mg/kg in the US guidelines. A specific duration of treatment of at least 6 months is only recommended in the European guidelines. All guidelines report the need of strict pregnancy prevention measures. The European, French and US guidelines recommend to monitor for symptoms of depression. Important clinical questions that are inconsistently addressed in guidelines include the age indication, the recommendation for a cumulative dose, the timing of procedures, the association of isotretinoin with IBD, the recommendation for preventing acne flares and for appropriate laboratory monitoring. These topics should be clearly included in the recommendations of guidelines as they are often raised in everyday clinical practice. 相似文献
56.
57.
58.
Anatoly E Martynyuk Ling-Sha Ju Timothy E Morey Jia-Qiang Zhang 《World Journal of Psychiatry》2020,10(5):81-94
The progress of modern medicine would be impossible without the use of general anesthetics (GAs). Despite advancements in refining anesthesia approaches, the effects of GAs are not fully reversible upon GA withdrawal. Neurocognitive deficiencies attributed to GA exposure may persist in neonates or endure for weeks to years in the elderly. Human studies on the mechanisms of the long-term adverse effects of GAs are needed to improve the safety of general anesthesia but they are hampered not only by ethical limitations specific to human research, but also by a lack of specific biological markers that can be used in human studies to safely and objectively study such effects. The latter can primarily be attributed to an insufficient understanding of the full range of the biological effects induced by GAs and the molecular mechanisms mediating such effects even in rodents, which are far more extensively studied than any other species. Our most recent experimental findings in rodents suggest that GAs may adversely affect many more people than is currently anticipated. Specifically, we have shown that anesthesia with the commonly used GA sevoflurane induces in exposed animals not only neuroendocrine abnormalities (somatic effects), but also epigenetic reprogramming of germ cells (germ cell effects). The latter may pass the neurobehavioral effects of parental sevoflurane exposure to the offspring, who may be affected even at levels of anesthesia that are not harmful to the exposed parents. The large number of patients who require general anesthesia, the even larger number of their future unexposed offspring whose health may be affected, and a growing number of neurodevelopmental disorders of unknown etiology underscore the translational importance of investigating the intergenerational effects of GAs. In this mini review, we discuss emerging experimental findings on neuroendocrine, epigenetic, and intergenerational effects of GAs. 相似文献
59.
T. Wu L. G. Trahair M. J. Bound C. F. Deacon M. Horowitz C. K. Rayner K. L. Jones 《Diabetic medicine》2015,32(5):595-600
60.
In 1963, Goffman argued that forming a group based on shared stigma may provide benefits. However, there is no empirical research on whether perception that a separate, unique, coherent group exists (i.e., group entitativity) influences coping, such as educating others or secrecy, for the stigmatized individual or his or her spouse. Further, little is known about how spouses influence each other in terms of promoting the education of others about a stigmatizing condition, especially when it comes to the role of believing that stigma-based groups, to which they may both belong, exist. This study provides a step toward bridging this gap in the research by applying the label management model in efforts to understand coping for couples in which one spouse is diagnosed with genetic mutations leading to alpha-1 antitrypsin deficiency (AATD). This study included 50 married couples in which one spouse is diagnosed with genetic mutations leading to alpha-1 antitrypsin deficiency (AATD). We found that group entitativity related to those with AATD counterbalanced the influence of genetic stigma on spouses’ intentions to keep the diagnosis secret or to educate others about it. Intrapersonal and interpersonal influences appeared among spouses. Attention is needed on the power of creating groups for stigmatized persons and their relatives. Indeed, people live within a dynamic world of group entities, and multiple social identities including spousal and familial. While attention has been paid to the diffusion of stigmas to loved ones, less has been paid to the uplift of group entities for them. 相似文献